ERFSF (Eurofins Scientific SE) Total Equity: $5,359 Mil (As of Dec. 2025)


ERFSF Eurofins Scientific SE ERFSF
81 GF Score
Price $76.03
GF Value $78.52
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Eurofins Scientific SE Total Equity?

Eurofins Scientific SE ERFSF +2.60% 81 Total Equity is $5,359 Mil as of Dec. 2025. GuruFocus rates ERFSF with a GF Score™ of 81/100 and a GF Value™ of $78.52 (Fairly Valued). The stock has 6 warning signs investors should review.

Eurofins Scientific SE's total equity for the quarter that ended in Dec. 2025 was $5,359 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Eurofins Scientific SE Total Equity Historical Data

* Premium members only.

The historical data trend for Eurofins Scientific SE's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE Total Equity Chart

Eurofins Scientific SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,284.86 5,138.77 5,602.40 5,638.53 5,359.13

Eurofins Scientific SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,602.40 5,701.72 5,638.53 5,388.12 5,359.13
ERFSF
81GF Score
Eurofins Scientific SE ERFSF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurofins Scientific SE Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Eurofins Scientific SE's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=12863.466-7504.333
=5,359

Eurofins Scientific SE's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=12863.466-7504.333
=5,359

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $5,359 Mil mean?
Eurofins Scientific SE (ERFSF) has a Total Equity of $5,359 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Eurofins Scientific SE and its competitors.
Is Eurofins Scientific SE's Total Equity too high?
Eurofins Scientific SE's current Total Equity is $5,359 Mil. Overall, Eurofins Scientific SE has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Total Equity compare to TMO and DHR?
Eurofins Scientific SE's Total Equity of $5,359 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Diagnostics & Research company?
A good Total Equity depends on the Medical Diagnostics & Research industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Eurofins Scientific SE and its competitors. Eurofins Scientific SE's current Total Equity is $5,359 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $78.52, compared to a current price of $76.03 — trading 3.2% below its estimated fair value. The current Total Equity is $5,359 Mil. Eurofins Scientific SE's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current Total Equity is $5,359 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be undervalued. The current stock price of $76.03 is trading 3.2% below its estimated GF Value™ of $78.52. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for ERFSF:

  • Total Equity: $5,359 Mil
  • GF Value™: $78.52 vs. price of $76.03 (3.2% below fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
81GF Score

Get the complete analysis for ERFSF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$76.03
Price
$78.52
GF Value